CRW Insider Trading

Insider Ownership Percentage: 20.83%
Insider Buying (Last 12 Months): £24,960
Insider Selling (Last 12 Months): GBX 0

Craneware Insider Trading History Chart

This chart shows the insider buying and selling history at Craneware by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Craneware Share Price & Price History

Current Price: GBX 2,240
Price Change: Price Decrease of -50 (-2.18%)
As of 04/25/2024 05:42 PM ET

This chart shows the closing price history over time for CRW up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Craneware Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/24/2023Will WhitehornInsiderBuy1,600GBX 1,560£24,960
3/13/2023Keith NeilsonInsiderBuy3,484GBX 1,435£49,995.40
2/1/2023Keith NeilsonInsiderBuy1,384GBX 1,445£19,998.80
1/26/2023Keith NeilsonInsiderBuy1,367GBX 1,455£19,889.85
9/22/2021Keith NeilsonInsiderBuy2,128GBX 2,350£50,008
See Full Table

SEC Filings (Institutional Ownership Changes) for Craneware (LON:CRW)

58.84% of Craneware stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Craneware logo
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers Trisus Decision Support; Trisus Labor Productivity; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, it offers appeal, professional, and pharmacy professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.
Read More on Craneware

Today's Range

Now: GBX 2,240
Low: 2,200
High: 2,300

50 Day Range

MA: GBX 2,176.79
Low: 2,070
High: 2,260

52 Week Range

Now: GBX 2,240
Low: 1,142
High: 2,300

Volume

60,888 shs

Average Volume

85,256 shs

Market Capitalization

£791.84 million

P/E Ratio

10,666.67

Dividend Yield

1.29%

Beta

0.14

Who are the company insiders with the largest holdings of Craneware?

Craneware's top insider investors include:
  1. Keith Neilson (Insider)
  2. Will Whitehorn (Insider)
Learn More about top insider investors at Craneware.